These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 33825131

  • 1. Pseudo-Bartter Syndrome and Intermediate Sweat Chloride Levels-It Could Still be Cystic Fibrosis!
    Kumar M, Varkki SD.
    Indian J Pediatr; 2021 Jun; 88(6):600. PubMed ID: 33825131
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cystic Fibrosis Presenting as Pseudo-Bartter Syndrome: An Important Diagnosis that is Missed!
    Mantoo MR, Kabra M, Kabra SK.
    Indian J Pediatr; 2020 Sep; 87(9):726-732. PubMed ID: 32504456
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Correlation of sweat chloride concentration with classes of the cystic fibrosis transmembrane conductance regulator gene mutations.
    Wilschanski M, Zielenski J, Markiewicz D, Tsui LC, Corey M, Levison H, Durie PR.
    J Pediatr; 1995 Nov; 127(5):705-10. PubMed ID: 7472820
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.
    Al-Mendalawi MD, Abdul-Wahab A, Janahi IA, Abdel-Rahman MO.
    Saudi Med J; 2010 Mar; 31(3):339-40; author reply 340. PubMed ID: 20231949
    [No Abstract] [Full Text] [Related]

  • 9. Mutations of the cystic fibrosis gene and intermediate sweat chloride levels in children.
    Lebecque P, Leal T, De Boeck C, Jaspers M, Cuppens H, Cassiman JJ.
    Am J Respir Crit Care Med; 2002 Mar 15; 165(6):757-61. PubMed ID: 11897640
    [Abstract] [Full Text] [Related]

  • 10. Screening for cystic fibrosis: the importance of using the correct tools.
    Shah U, Moatter T.
    J Ayub Med Coll Abbottabad; 2006 Mar 15; 18(1):7-10. PubMed ID: 16773960
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cystic fibrosis screen-positive neonates with one pathogenic variant still warrant sweat testing.
    Rock MJ, Baker M, Farrell PM.
    Pediatr Pulmonol; 2023 Nov 15; 58(11):3342-3345. PubMed ID: 37503874
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cystic fibrosis: need for mass deployable screening methods.
    Sengar AS, Agarwal A, Singh MK.
    Appl Biochem Biotechnol; 2014 Oct 15; 174(3):1127-36. PubMed ID: 24880895
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.